nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromopride—DRD2—schizophrenia	0.889	1	CbGaD
Bromopride—DRD2—Dopamine receptors—DRD1—schizophrenia	0.0052	0.051	CbGpPWpGaD
Bromopride—DRD2—Dopamine receptors—DRD3—schizophrenia	0.00503	0.0494	CbGpPWpGaD
Bromopride—DRD2—Dopamine receptors—DRD4—schizophrenia	0.00489	0.0479	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—PPP1R1B—schizophrenia	0.00386	0.0379	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRIN2D—schizophrenia	0.00265	0.026	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRIN2C—schizophrenia	0.00265	0.026	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—SLC18A2—schizophrenia	0.00224	0.022	CbGpPWpGaD
Bromopride—Chloroprocaine—HTR3A—schizophrenia	0.00223	0.259	CrCbGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—schizophrenia	0.00222	0.0218	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—TAAR6—schizophrenia	0.00198	0.0194	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—HTR6—schizophrenia	0.00196	0.0193	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—schizophrenia	0.00195	0.0192	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—schizophrenia	0.00177	0.0174	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—CHRM1—schizophrenia	0.00173	0.017	CbGpPWpGaD
Bromopride—Metoclopramide—HTR3A—schizophrenia	0.00173	0.202	CrCbGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRM5—schizophrenia	0.00165	0.0162	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—HTR6—schizophrenia	0.00165	0.0162	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRIN1—schizophrenia	0.00162	0.0159	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—schizophrenia	0.0016	0.0157	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—schizophrenia	0.00155	0.0152	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRIN2A—schizophrenia	0.00147	0.0144	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—CAMK2B—schizophrenia	0.00147	0.0144	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRIA1—schizophrenia	0.00147	0.0144	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—TH—schizophrenia	0.00147	0.0144	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—CHRM1—schizophrenia	0.00146	0.0143	CbGpPWpGaD
Bromopride—Metoclopramide—CHRM1—schizophrenia	0.00129	0.15	CrCbGaD
Bromopride—DRD2—Monoamine GPCRs—HTR1B—schizophrenia	0.00124	0.0121	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—EGR3—schizophrenia	0.00121	0.0118	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—HTR1A—schizophrenia	0.00119	0.0117	CbGpPWpGaD
Bromopride—Chloroprocaine—SLC6A3—schizophrenia	0.00118	0.138	CrCbGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—DRD1—schizophrenia	0.00118	0.0115	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—DRD1—schizophrenia	0.00115	0.0113	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—HTR2C—schizophrenia	0.00115	0.0113	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—DRD3—schizophrenia	0.00111	0.0109	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—DRD4—schizophrenia	0.00111	0.0109	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—DRD4—schizophrenia	0.00108	0.0106	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRIN2B—schizophrenia	0.00106	0.0104	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—HTR1B—schizophrenia	0.00104	0.0102	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—HTR7—schizophrenia	0.00101	0.00987	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—HTR1A—schizophrenia	0.001	0.00981	CbGpPWpGaD
Bromopride—Metoclopramide—DRD3—schizophrenia	0.000986	0.115	CrCbGaD
Bromopride—DRD2—Amine ligand-binding receptors—HTR2C—schizophrenia	0.000965	0.00947	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—DRD1—schizophrenia	0.000965	0.00947	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—DRD3—schizophrenia	0.000935	0.00917	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—DRD4—schizophrenia	0.000908	0.0089	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—HTR7—schizophrenia	0.000846	0.0083	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—HTR2A—schizophrenia	0.000705	0.00691	CbGpPWpGaD
Bromopride—Metoclopramide—DRD2—schizophrenia	0.000682	0.0796	CrCbGaD
Bromopride—DRD2—Amine ligand-binding receptors—HTR2A—schizophrenia	0.000592	0.00581	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—GRM2—schizophrenia	0.000489	0.0048	CbGpPWpGaD
Bromopride—Metoclopramide—CYP2D6—schizophrenia	0.000482	0.0562	CrCbGaD
Bromopride—DRD2—Circadian rythm related genes—TPH1—schizophrenia	0.000447	0.00438	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—GRM3—schizophrenia	0.000416	0.00408	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—RGS4—schizophrenia	0.000416	0.00408	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—CHRM1—schizophrenia	0.000409	0.00401	CbGpPWpGaD
Bromopride—DRD2—telencephalic ventricle—schizophrenia	0.000401	0.426	CbGeAlD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.000389	0.00381	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR6—schizophrenia	0.000379	0.00372	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.000352	0.00345	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—CLOCK—schizophrenia	0.000347	0.00341	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—TPH2—schizophrenia	0.000339	0.00332	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.000335	0.00328	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.000325	0.00318	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—ADORA2A—schizophrenia	0.000323	0.00317	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—CHRNB2—schizophrenia	0.000321	0.00315	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—FZD3—schizophrenia	0.000315	0.00309	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—GRM2—schizophrenia	0.000296	0.0029	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—TAAR6—schizophrenia	0.000296	0.0029	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.000287	0.00281	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—NPS—schizophrenia	0.000276	0.00271	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.000273	0.00268	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—SLC6A4—schizophrenia	0.000271	0.00265	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—DRD1—schizophrenia	0.000271	0.00265	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—NTS—schizophrenia	0.000268	0.00263	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—NPY—schizophrenia	0.000266	0.00261	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.000264	0.00259	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—DRD3—schizophrenia	0.000262	0.00257	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—HTR1B—schizophrenia	0.000257	0.00252	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—DRD4—schizophrenia	0.000254	0.0025	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—GRM3—schizophrenia	0.000252	0.00247	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—HTR1A—schizophrenia	0.000247	0.00243	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR6—schizophrenia	0.000247	0.00242	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.000244	0.00239	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—TH—schizophrenia	0.000241	0.00237	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.000238	0.00234	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—HTR7—schizophrenia	0.000237	0.00233	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.000234	0.00229	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—DRD3—schizophrenia	0.000231	0.00227	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.000229	0.00225	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.000227	0.00222	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—DRD4—schizophrenia	0.000225	0.0022	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.000222	0.00217	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.000222	0.00217	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—CHRM1—schizophrenia	0.000218	0.00214	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.000215	0.00211	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—CNR1—schizophrenia	0.000214	0.0021	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.000212	0.00208	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—DGKI—schizophrenia	0.000209	0.00205	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.000208	0.00204	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.000204	0.002	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.000204	0.002	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—GRM5—schizophrenia	0.000203	0.00199	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.000199	0.00195	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.000197	0.00193	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.000194	0.0019	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.000194	0.0019	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—DGKI—schizophrenia	0.00019	0.00186	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00019	0.00186	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00019	0.00186	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—CCK—schizophrenia	0.000186	0.00182	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.000184	0.0018	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.000179	0.00175	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—CCKAR—schizophrenia	0.000178	0.00175	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—PPP1R1B—schizophrenia	0.000174	0.00171	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—ADORA2A—schizophrenia	0.000173	0.00169	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00017	0.00167	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—GRM2—schizophrenia	0.000167	0.00164	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—TAAR6—schizophrenia	0.000167	0.00164	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.000166	0.00163	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—FZD3—schizophrenia	0.000162	0.00159	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—NPY—schizophrenia	0.000161	0.00158	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR1B—schizophrenia	0.000156	0.00153	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—OXT—schizophrenia	0.000156	0.00153	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—NGEF—schizophrenia	0.000155	0.00152	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—PPP3CC—schizophrenia	0.000152	0.00149	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—GRM2—schizophrenia	0.000152	0.00149	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—TAAR6—schizophrenia	0.000152	0.00149	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—NTS—schizophrenia	0.000151	0.00148	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR1A—schizophrenia	0.00015	0.00147	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—NPS—schizophrenia	0.000147	0.00145	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR2C—schizophrenia	0.000145	0.00142	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—DRD1—schizophrenia	0.000145	0.00142	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—RGS4—schizophrenia	0.000142	0.0014	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—GRM3—schizophrenia	0.000142	0.0014	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—NGEF—schizophrenia	0.000141	0.00138	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—DRD3—schizophrenia	0.00014	0.00137	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR6—schizophrenia	0.00014	0.00137	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—NTS—schizophrenia	0.000137	0.00135	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.000136	0.00133	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—DRD4—schizophrenia	0.000136	0.00133	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—GSK3B—schizophrenia	0.000134	0.00131	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—CNR1—schizophrenia	0.00013	0.00127	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—RGS4—schizophrenia	0.000129	0.00127	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—GRM3—schizophrenia	0.000129	0.00127	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR6—schizophrenia	0.000127	0.00124	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR7—schizophrenia	0.000127	0.00124	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—CHRM1—schizophrenia	0.000123	0.00121	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—IL3RA—schizophrenia	0.00012	0.00118	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000116	0.00114	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—GRM5—schizophrenia	0.000115	0.00113	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—DGKI—schizophrenia	0.000112	0.0011	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—CHRM1—schizophrenia	0.000112	0.0011	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—IL3RA—schizophrenia	0.000109	0.00107	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—CCK—schizophrenia	0.000105	0.00103	CbGpPWpGaD
Bromopride—DRD2—forebrain—schizophrenia	0.000105	0.111	CbGeAlD
Bromopride—DRD2—Signaling by GPCR—GRM5—schizophrenia	0.000104	0.00102	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—PPP1R1B—schizophrenia	0.000103	0.00101	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—PDE4B—schizophrenia	0.000102	0.001	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—CCKAR—schizophrenia	0.000101	0.000987	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—ADORA2A—schizophrenia	9.75e-05	0.000957	CbGpPWpGaD
Bromopride—DRD2—telencephalon—schizophrenia	9.62e-05	0.102	CbGeAlD
Bromopride—DRD2—Signaling Pathways—FZD3—schizophrenia	9.55e-05	0.000937	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—CCK—schizophrenia	9.53e-05	0.000934	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—PDE4B—schizophrenia	9.28e-05	0.000911	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—CCKAR—schizophrenia	9.13e-05	0.000896	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—NPY—schizophrenia	9.11e-05	0.000894	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GRM2—schizophrenia	8.98e-05	0.000881	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—FES—schizophrenia	8.98e-05	0.000881	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—TAAR6—schizophrenia	8.98e-05	0.000881	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—PPP3CC—schizophrenia	8.98e-05	0.000881	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR2A—schizophrenia	8.87e-05	0.00087	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—ADORA2A—schizophrenia	8.86e-05	0.000869	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—EP300—schizophrenia	8.8e-05	0.000863	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR1B—schizophrenia	8.79e-05	0.000862	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—OXT—schizophrenia	8.79e-05	0.000862	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR1A—schizophrenia	8.46e-05	0.00083	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—NPS—schizophrenia	8.33e-05	0.000817	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—NGEF—schizophrenia	8.31e-05	0.000815	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—NPY—schizophrenia	8.27e-05	0.000812	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—DRD1—schizophrenia	8.17e-05	0.000802	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR2C—schizophrenia	8.17e-05	0.000802	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—NTS—schizophrenia	8.12e-05	0.000796	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR1B—schizophrenia	7.98e-05	0.000783	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—OXT—schizophrenia	7.98e-05	0.000783	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—DRD3—schizophrenia	7.91e-05	0.000776	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR1A—schizophrenia	7.68e-05	0.000754	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—DRD4—schizophrenia	7.68e-05	0.000754	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—RTN4—schizophrenia	7.63e-05	0.000749	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—RGS4—schizophrenia	7.63e-05	0.000749	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GRM3—schizophrenia	7.63e-05	0.000749	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—NPS—schizophrenia	7.57e-05	0.000742	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR6—schizophrenia	7.49e-05	0.000735	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—DRD1—schizophrenia	7.42e-05	0.000728	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR2C—schizophrenia	7.42e-05	0.000728	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—CNR1—schizophrenia	7.34e-05	0.00072	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—MAG—schizophrenia	7.24e-05	0.00071	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—DRD3—schizophrenia	7.19e-05	0.000705	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR7—schizophrenia	7.16e-05	0.000702	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—DRD4—schizophrenia	6.98e-05	0.000684	CbGpPWpGaD
Bromopride—DRD2—midbrain—schizophrenia	6.91e-05	0.0735	CbGeAlD
Bromopride—DRD2—Signaling by GPCR—CNR1—schizophrenia	6.66e-05	0.000654	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—CHRM1—schizophrenia	6.62e-05	0.000649	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR7—schizophrenia	6.5e-05	0.000638	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—IL3RA—schizophrenia	6.45e-05	0.000633	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—NRG3—schizophrenia	6.29e-05	0.000618	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—TLE1—schizophrenia	6.29e-05	0.000618	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—TP53—schizophrenia	6.29e-05	0.000617	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GFAP—schizophrenia	6.22e-05	0.00061	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GRM5—schizophrenia	6.15e-05	0.000604	CbGpPWpGaD
Bromopride—DRD2—endocrine gland—schizophrenia	6.07e-05	0.0646	CbGeAlD
Bromopride—DRD2—Signaling Pathways—TLE3—schizophrenia	5.96e-05	0.000585	CbGpPWpGaD
Bromopride—DRD2—nervous system—schizophrenia	5.68e-05	0.0604	CbGeAlD
Bromopride—DRD2—Signaling Pathways—CCK—schizophrenia	5.63e-05	0.000552	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—PDE4B—schizophrenia	5.48e-05	0.000538	CbGpPWpGaD
Bromopride—DRD2—central nervous system—schizophrenia	5.47e-05	0.0582	CbGeAlD
Bromopride—DRD2—Signaling Pathways—CCKAR—schizophrenia	5.39e-05	0.000529	CbGpPWpGaD
Bromopride—DRD2—cerebellum—schizophrenia	5.35e-05	0.0569	CbGeAlD
Bromopride—DRD2—Signaling Pathways—ADORA2A—schizophrenia	5.23e-05	0.000513	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—PLA2G4A—schizophrenia	5.14e-05	0.000505	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—FGA—schizophrenia	5.02e-05	0.000492	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR2A—schizophrenia	5.01e-05	0.000492	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—NPY—schizophrenia	4.89e-05	0.000479	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—NOTCH4—schizophrenia	4.89e-05	0.000479	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—ATP2A2—schizophrenia	4.89e-05	0.000479	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—OXT—schizophrenia	4.72e-05	0.000463	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR1B—schizophrenia	4.72e-05	0.000463	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR2A—schizophrenia	4.55e-05	0.000447	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR1A—schizophrenia	4.54e-05	0.000445	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—NPS—schizophrenia	4.47e-05	0.000439	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR2C—schizophrenia	4.38e-05	0.00043	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—DRD1—schizophrenia	4.38e-05	0.00043	CbGpPWpGaD
Bromopride—DRD2—brain—schizophrenia	4.34e-05	0.0462	CbGeAlD
Bromopride—DRD2—Signaling Pathways—NTRK2—schizophrenia	4.26e-05	0.000418	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—DRD3—schizophrenia	4.25e-05	0.000417	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—DRD4—schizophrenia	4.12e-05	0.000404	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—CNR1—schizophrenia	3.94e-05	0.000386	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR7—schizophrenia	3.84e-05	0.000377	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—PRL—schizophrenia	3.63e-05	0.000356	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—S100B—schizophrenia	3.38e-05	0.000332	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—ERBB4—schizophrenia	3.23e-05	0.000317	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—PLA2G4A—schizophrenia	3.04e-05	0.000298	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—NRG1—schizophrenia	2.98e-05	0.000293	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—MEF2C—schizophrenia	2.96e-05	0.00029	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—YWHAZ—schizophrenia	2.86e-05	0.00028	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—ERBB3—schizophrenia	2.79e-05	0.000274	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR2A—schizophrenia	2.69e-05	0.000264	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—APOE—schizophrenia	2.5e-05	0.000245	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—APOA1—schizophrenia	2.47e-05	0.000242	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—ESR1—schizophrenia	2.39e-05	0.000234	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GSK3B—schizophrenia	2.17e-05	0.000212	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—AKT1—schizophrenia	1.6e-05	0.000157	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—AKT1—schizophrenia	1.46e-05	0.000143	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—EP300—schizophrenia	1.42e-05	0.00014	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—TP53—schizophrenia	1.02e-05	0.0001	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—AKT1—schizophrenia	8.61e-06	8.45e-05	CbGpPWpGaD
